Biological Activities ofLibidibia (Caesalpinia) ferreavar.parvifolia(Mart. ex Tul.) L. P. Queiroz Pod Preparations

Author:

Freitas A. C. C.1,Ximenes N. C. A.1,Aguiar J. S.2,Nascimento S. C.2,Lins T. U. L.2,Magalhães L. R.2,Coelho L. C. B. B.1,Carneiro-da-Cunha M. G.1,Gonçalves-Silva T.2,Correia M. T. S.1

Affiliation:

1. Laboratório de Glicoproteínas, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco (UFPE), Avenida Professor Moraes Rego s/n, Cidade Universitária, 50670-420 Recife, PE, Brazil

2. Laboratório de Bioensaios para Pesquisa de Fármacos, Departamento de Antibióticos, Centro de Ciências Biológicas, Universidade Federal de Pernambuco (UFPE), Avenida Professor Moraes Rego s/n, Cidade Universitária, 50670-420 Recife, PE, Brazil

Abstract

Libidibia ferreahas been used in folk medicine throughout Brazil, and this study evaluated the biological activities of crude extract (CE) as well as a partially purified fraction (F80) obtained from its pods. Results from the MTT assay revealed that only F80 inhibited NCI-H292 cell growth; however, neither CE nor F80 reduced HEp-2 cell growth or sarcoma 180 tumor weight with thein vivoassay. Acute oral toxicity of the extract and fraction was evaluated following the steps of Guideline 423, using female mice;LD50for both preparations was determined as 2,500 mg/kg body weight. CE and F80 promoted a reduction of the leukocyte number and nitrite level in inflammatory exudates when the anti-inflammatory assay (carrageenan-induced peritonitis) was performed. CE and F80 inhibited writhing regarding antinociceptive activity (acetic acid-induced writhing response in mice). In conclusion, CE and F80 have no significant cytotoxic or antitumor activities in cell lines showing low toxicity and no action against tumorsin vivo. Both preparations revealed anti-inflammatory and antinociceptive activities, corroborating the pharmacological basis ofL. ferreafor ethnomedical use.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3